文献速递泌尿生殖介入US

血压对经皮肾活检全程活检后出血风险的影响

The impact of blood pressure on the risk of postbiopsy bleeding during the whole procedure of percutaneous kidney biopsy.
PubMed 文献 · Abdom Radiol (NY) · 2022-12-27

本研究回顾性分析1146例超声引导下自体肾穿刺活检,发现37.7%患者发生活检后出血,7.7%为大出血并发症。术前收缩压≥160 mmHg或舒张压≥100 mmHg者大出血比例更高,术后舒张压≥85–100 mmHg者大出血率亦升高,提示围术期血压高于特定阈值与出血风险相关。

要点

  • 术前收缩压≥160 mmHg者大出血率为17.6%,低于此阈值者为7.5%。
  • 术前舒张压≥100 mmHg者大出血率为19.0%,低于此阈值者为7.5%。
  • 术后舒张压≥85–100 mmHg者大出血率为9.5–17.5%,需关注术后血压管理。

诊断标准与关键数值

  • 术前收缩压≥160 mmHg者大出血并发症率为17.6%,收缩压<160 mmHg者为7.5%。
  • 术前舒张压≥100 mmHg者大出血并发症率为19.0%,舒张压<100 mmHg者为7.5%。
  • 术后舒张压≥85 mmHg至100 mmHg者大出血并发症率为9.5%至17.5%,舒张压<100 mmHg至85 mmHg者为6.6%至7.3%。
  • 采用ROC曲线探索区分出血与非出血的最佳血压阈值。

临床应用与阅片要点

  • 肾活检术前应关注收缩压是否≥160 mmHg及舒张压是否≥100 mmHg,高于阈值者出血风险增加。
  • 术后舒张压处于85–100 mmHg区间时大出血率较高,阅片报告及临床交接中应提示临床关注血压管理。

局限性

  • 本研究为回顾性横断面设计,可能存在未测量的混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To investigate whether BP is related to postbiopsy bleeding in patients undergoing native percutaneous kidney biopsy (PKB) and to evaluate the dynamic changes in blood pressure (BP) pre- and post-kidney biopsy.

METHODS: A retrospective cross-sectional study was conducted. The whole-procedural systolic (SBP) and diastolic (DBP) BP for patients undergoing ultrasound-guided native PKB from October 2017 to December 2020 were recorded in the study. Propensity score matching was used to minimize selection bias. SBP and DBP were analyzed as the main risk factors for bleeding complications. Receiver operating characteristic (ROC) curves were employed to explore the optimal BP thresholds to differentiate between bleeding and nonbleeding. The rates of major bleeding complications were analyzed according to BP thresholds through logistic analysis.

RESULTS: Of 1146 biopsies, 432 (37.7%) patients suffered from postbiopsy bleeding, 88 (7.7%) patients had major bleeding complications, and 344 (30.0%) patients had minor bleeding complications. In the original data, for patients with SBP ≥ 160 mmHg before PKB, the rate of major bleeding complications was 17.6% (7.5% for SBP < 160 mmHg), and the rate of major bleeding complications was 19.0% in patients with DBP ≥ 100 mmHg (7.5% for DBP < 100 mmHg). For patients with DBP ≥ 85 mmHg to 100 mmHg after PKB, the rate of major bleeding complications ranged from 9.5 to 17.5%. The rate of major bleeding complications was lower (6.6-7.3%) in patients with DBP < 100 mmHg to 85 mmHg.

CONCLUSION: Patients who have high-level BP during the native PKB perioperative period are at higher risk for postbiopsy bleeding. High-level BP here does not refer to traditional hypertension according to the guidelines for the diagnosis and treatment of hypertension, but rather BP above a certain threshold related to bleeding risk.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Guan, Bai, Li, et al. The impact of blood pressure on the risk of postbiopsy bleeding during the whole procedure of percutaneous kidney biopsy. Abdom Radiol (NY). 2022. PMID: 36574058. doi:10.1007/s00261-022-03781-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。